Table 2.
Key themes discussed in articles (n = 344) by newspaper genre.
| Manifest themes discussed in articles | Newspaper ‘genre’ |
All |
|||
|---|---|---|---|---|---|
| ‘Serious’ |
‘Middle-market tabloid’ |
‘Tabloid’ |
X2 (2df) (p value) |
No of articles (% total) |
|
| n (column %) | |||||
| Development, vaccine trials and introduction of HPV programme | 187 (96.9) | 72 (93.5) | 63 (85.1) | 12.35 (0.002) | 322 (93.6) |
| HPV as causal agent in cervical cancer | 165 (85.5) | 73 (94.8) | 71 (95.9) | 9.09 (0.011) | 309 (89.8) |
| The target age and rationale for target age | 193 (76.7) | 77 (79.2) | 74 (60.8) | 8.46 (0.15) | 254 (73.8) |
| Prevalence of HPV | 133 (68.9) | 56 (72.7) | 57 (77.0) | 1.80 (0.406) | 246 (71.8) |
| Explicit mention of HPV as sexually transmitted infection | 131 (67.9) | 61 (79.2) | 46 (62.2) | 5.51 (0.064) | 238 (69.2) |
| Names of pharmaceutical companies developing vaccine or product name (Gardasil or Cervarix) | 114 (59.1) | 43 (55.8) | 25 (33.8) | 14.07 (0.001) | 182 (52.9) |
| Green light to sex/promiscuity | 98 (50.8) | 41 (53.2) | 25 (33.8) | 7.43 (0.024) | 164 (47.7) |
| Safety and efficacy of HPV | 96 (49.7) | 43 (55.8) | 25 (33.8) | 8.11 (0.017) | 164 (47.7) |
| Parents attitudes or behaviours towards HPV vaccination | 75 (38.9) | 42 (54.5) | 16 (21.6) | 17.26 (<0.0001) | 133 (38.7) |
| Explicit mention of benefits of HPV vaccination | 74 (38.3) | 34 (44.2) | 23 (31.1) | 2.75 (0.253) | 131 (38.1) |
| Explicit mention of HPV vaccination monetary costs | 80 (41.5%) | 37 (48.1) | 14 (18.9) | 15.70 (<0.0001) | 131 (38.1) |
| Impact on cervical screening | 61 (31.6) | 31 (40.3) | 18 (24.3) | 4.43 (0.109) | 110 (32.0) |
| Comparing UK HPV policy with HPV policy in other countries | 53 (27.5) | 17 (22.1) | 8 (10.8) | 8.48 (0.014) | 78 (22.7) |
| Catch up programme | 42 (21.8) | 16 (20.8) | 8 (10.8) | 4.30 (0.117) | 66 (19.2) |
| Anti-immunisation sentiments | 39 (20.2) | 19 (24.7) | 1 (1.4) | 17.34 (<0.0001) | 59 (17.2) |
| HPV and women above 18 years of age | 37 (19.2) | 13 (16.9) | 8 (10.8) | 2.67 (0.264) | 58 (16.9) |
| Health professionals' role in HPV programme | 35 (18.1) | 13 (16.9) | 2 (2.7) | 10.70 (0.005) | 50 (14.5) |
| Getting HPV privately | 29 (15.0) | 11 (14.3) | 3 (4.1) | 6.18 (0.046) | 43 (12.5) |
| Whether vaccination should be compulsory or voluntary | 28 (14.5) | 11 (14.3) | 3 (4.1) | 5.85 (0.054) | 42 (12.2) |
| Herd/population immunity | 14 (7.3) | 10 (13.0) | 2 (2.7) | 5.77 (0.056) | 26 (7.6) |
| Sex education on HPV | 15 (7.8) | 6 (7.8) | 4 (5.4) | 0.49 (0.785) | 25 (7.3) |
| Total | 193 | 77 | 74 | – | 344 |